Clinical trial

Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the…

NCT00108810 · ZARS Pharma Inc., Industry · Completed

Key facts

NCT number NCT00108810
Title Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee
Official title Randomized, Double-Blind, Parallel, Placebo Controlled 4 Week Proof-of-Concept Study to Evaluate the Safety and Efficacy of Transdermal Ketoprofen When Administered With Controlled Heat in Patients With Mild to Moderate OA Pain of the Knee
Lead sponsor ZARS Pharma Inc., Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Pain, Osteoarthritis, Knee
Intervention type Drug
Interventions Transdermal Ketoprofen Patch with CHADD, Placebo transdermal patch
Enrollment 118
Start date Apr 1, 2005
Primary completion Oct 1, 2005
Completion Oct 1, 2005
First posted Apr 19, 2005
Last update posted Jun 5, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies